Mindray Medical International Ltd Target of Unusually Large Options Trading (MR)
Shares of Mindray Medical International Ltd (NYSE:MR) were the recipient of some unusual options trading activity on Wednesday. Stock investors acquired 512 call options on the stock, Analyst Ratings Net reports. This is an increase of approximately 201% compared to the typical daily volume of 170 call options.
A number of analysts have recently weighed in on MR shares. Analysts at Zacks reiterated a “neutral” rating on shares of Mindray Medical International Ltd in a research note on Wednesday. They now have a $32.00 price target on the stock. Analysts at Jefferies Group cut their price target on shares of Mindray Medical International Ltd from $36.00 to $32.00 in a research note on Thursday, May 22nd. They now have a “hold” rating on the stock. Six research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $34.30.
Shares of Mindray Medical International Ltd (NYSE:MR) traded down 1.04% on Wednesday, hitting $30.50. The stock had a trading volume of 551,084 shares. Mindray Medical International Ltd has a 52 week low of $28.54 and a 52 week high of $43.71. The stock has a 50-day moving average of $30.70 and a 200-day moving average of $32.28. The company has a market cap of $3.568 billion and a price-to-earnings ratio of 18.25.
Mindray Medical International Ltd (NYSE:MR) last posted its quarterly earnings results on Monday, August 11th. The company reported $0.56 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.54 by $0.02. The company had revenue of $334.50 million for the quarter, compared to the consensus estimate of $348.30 million. During the same quarter last year, the company posted $0.56 earnings per share. Mindray Medical International Ltd’s revenue was up 8.9% compared to the same quarter last year. On average, analysts predict that Mindray Medical International Ltd will post $1.86 earnings per share for the current fiscal year.
Mindray Medical International Limited (NYSE:MR), is a developer, manufacturer and marketer of medical devices worldwide.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.